Jeffrey Augen

Jeff Augen, currently a private investor and writer, has spent more than a decade building a unique intellectual property portfolio of algorithms and software for technical analysis of derivatives prices. His work includes more than one million lines of computer code reflecting powerful new strategies for trading options, futures, and currencies in markets dominated by high frequency trading (HFT). As a result, he now provides real-time access to an unusual blend of market insight, trading strategies, and proprietary trading tools through his own service at PhaseTraderIndicator.com. Members of the service receive access to weekly in-depth Market Reviews and live Webinars as well as the PhaseTrader® Indicator tool suite. For more information about Jeff’s service please visit https://phasetraderindicator.com/visitors-center/ .

Augen has a 30-year history in information technology. As co-founding executive of IBM's Life Sciences Computing business, he defined a growth strategy that resulted in $1.2 billion of new revenue, and managed a large portfolio of venture capital investments. From 2002 to 2005, Augen was President and CEO of TurboWorx, Inc., a technical computing software company founded by the chairman of the Department of Computer Science at Yale University. He is author of The Volatility Edge in Options Trading (FT Press, 2008), The Option Trader's Workbook (FT Press, 2008), Trading Options at Expirations (FT Press, 2009), Day Trading Options (FT Press, 2009), and Bioinformatics in the Post-Genomic Era (Addison-Wesley, 2004). Much of his current work on derivatives pricing is built on algorithms for predicting molecular structures that he developed as a graduate student.